NCT03055858View on ClinicalTrials.gov

AMPLATZER Duct Occluder II Additional Sizes

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 5, 2017

Primary Completion Date

September 25, 2019

Study Completion Date

April 5, 2022

Conditions
Patent Ductus Arteriosus
Interventions
DEVICE

ADO II AS (PDA closure)

Closure of PDA using Amplatzer Duct Occluder II Additional Sizes (ADO II AS).

Trial Locations (9)

19104

Children's Hospital of Philadelphia, Philadelphia

32806

Arnold Palmer Hospital, Orlando

38105

Methodist LeBonheur Healthcare, Memphis

43205

Nationwide Children's Hospital, Columbus

48201

Children's Hospital of Michigan, Detroit

63110

St. Louis Children's Hospital, St Louis

77030

Texas Children's Hospital, Houston

90048

Cedars Sinai Medical Center, Los Angeles

98105

Seattle Children's Hospital, Seattle

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY